MedPath

Support for Physical Activity in Everyday Life With Parkinson's Disease

Not Applicable
Active, not recruiting
Conditions
Parkinson Disease
eHealth
Gait Disorders, Neurologic
Physical Activity
Registration Number
NCT05510739
Lead Sponsor
Stiftelsen Stockholms Sjukhem
Brief Summary

This study aims to determine the effects of a motor-cognitive exercise intervention, delivered in the home environment using eHealth methods, among people with Parkinson's disease. The intervention will support and motivate motor training, combined with cognitive training, aimed at attentional and executive functions, among people at mild-moderate disease stages. The main hypothesis is that unsupervised motor-cognitive training in the home environment using eHealth will lead to improvements in gait performance, increased physical activity levels and improved perceived health.

Detailed Description

This randomised controlled trial will investigate the efficacy of a motor-cognitive exercise program in the home environment, over a 10-week period, on physical function, and motor-cognitive dual task function as well as physical activity behavior in everyday life. A follow-up assessment comprising health-related questionnaires and physical activity monitoring will be conducted at one year post-intervention. Participants will be recruited through Stockholms sjukhem foundation, Karolinska University and via announcements in relevant forums like for instance the Swedish Parkinson Association. Consenting participants will be randomized to the eHealth Intervention group or the control group condition. Block randomization will be achieved using a computerized random sequence generator. Blinded assessors will perform the pre- and post-intervention testing of physical performance.

The ultimate aim of this project is to provide people with PD with continual long-term and evidence-based rehabilitation in their everyday lives using mobile health technology, to support their self- management and increase their quality of life.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Diagnosis of idiopathic Parkinson´s disease
  • Hoehn & Yahr (Parkinsons progression scale) 2-3
  • ≥ 50 years of age
  • Able to ambulate indoors without mobility aid
  • Able to walk continually with/without a walking aid for at least 6 minutes
Exclusion Criteria
  • Cognitive impairment affecting the ability to understand or follow verbal or written instructions (Montreal Cognitive Assessment ≤ 21 points
  • Major problems with freezing and/or two or more falls in the month previous to inclusion
  • Other existing neurological/ orthopedic or cardiovascular disease which impedes the performance of unsupervised exercise
  • Impaired vision and/or impaired communication which hinders participation
  • No internet connection in the home

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The six minute walk testChange in balance performance at 10 weeks

This test measures walking capacity by measuring the distance covered (meters) over a time period of 6 minutes.

Secondary Outcome Measures
NameTimeMethod
Physical activity measured with accelerometersChange at 10 weeks and one year post-intervention

Steps per day and time (minutes) in different physical activity intensities (high,moderate and low intensity)

Balance ConfidenceChange at 10 weeks and one year post-intervention

The Activities-specific Balance Confidence scale is a measure of confidence performing in various activities without losing balance or experiencing unsteadiness. A 16-item self-report measure with items rated on a rating scale that ranges from 0-100. A higher score indicates higher balance confidence.

Health-related Quality of LifeChange at 10 weeks and one year post-intervention

The EQ-5D is a two-part instrument that measures health-related quality of life. It examines 5 domains of quality of life: mobility, self-care, daily activities, pain, anxiety/depression. It comprises 5 questions and a visual scale.

Exercise Self-EfficacyChange at 10 weeks and one year post-intervention

The Exercise Self-Efficacy Scale is an instrument examining confidence regarding carrying out regular physical activities and exercise. Questions are answered on a 4-point rating scale. A higher score indicates greater confidence.

Global Positioning SystemChange at 10 weeks and one year post-intervention in only the final cohort of participants

GPS monitors collecting participant daily location and movement data via latitude and longitude coordinates collected throughout waking hours.

Quality of life questionnairesChange at 10 weeks and one year post-intervention

PDQ-39 is disease specific quality of life questionnaire. Items are grouped into eight scales that are scored by expressing summed item scores as a percentage score ranging between 0 and 100

Life Space AssessmentChange at 10 weeks and one year post-intervention in only the final cohort of participants

The LSA is a self-report measure of the frequency of independent mobility across 5 life-space levels. Higher scores indicate more life-space and movement throughout the community.

Executive functionChange at 10 weeks

Trail making test A \& B. Expressed as time required to perform the test (seconds)

Gait parameters during single and dual-task conditionsChange at 10 weeks

Stride length (meters); Cadence (steps/ minute) will be captured using born-worn inertial sensors

Walking abilityChange at 10 weeks and one year post-intervention

The Walk-12 questionnaire examines limitations in walking ability. It consists of 12 questions answered on either a 3-point or 5-point rating scale.

Hospital Anxiety and Depression ScaleChange at 10 weeks and one year post-intervention

A 14-item measure designed to reflect the state of generalised anxiety and depression. The respondent rates each item on a 4-point scale. Higher scores indicate greater levels of anxiety or depression.

Dual-task ability during walkingChange at 10 weeks

Captured using the Auditory Stroop test during walking and expressed as percentage error of the task

Balance abilityChange at 10 weeks

MiniBest test. Scoring 0-28, lower scores = greater balance impairment

Trial Locations

Locations (1)

Stockholms sjukhem

🇸🇪

Stockholm, Sweden

Stockholms sjukhem
🇸🇪Stockholm, Sweden
Breiffni Leavy, PhD
Contact
0852488814
breiffni.leavy@ki.se

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.